Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CGC
CGC logo

CGC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Canopy Growth Corp (CGC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.860
1 Day change
-4.14%
52 Week Range
2.380
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Canopy Growth Corp (CGC) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is weak, with declining revenue, net income, and gross margins. Technical indicators suggest a bearish trend, and there are no strong positive catalysts or proprietary trading signals to justify an entry point. The stock's future prospects are uncertain due to regulatory challenges in the cannabis industry, and analysts have lowered their price targets. Given these factors, holding off on investing in CGC is recommended.

Technical Analysis

The stock is in a bearish trend with MACD below 0 and negatively expanding, RSI at 26.108 in the neutral zone, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). The price is trading near its support level of 0.913, with resistance at 0.993. Overall, the technical indicators do not suggest a favorable entry point.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
5

Positive Catalysts

  • No significant positive catalysts identified.

Neutral/Negative Catalysts

  • Heavy regulation and uncertainty in the cannabis industry, declining financial performance, and reduced analyst price targets. Additionally, the stock is trading in a bearish technical setup.

Financial Performance

In Q3 2026, revenue dropped by -0.29% YoY to CA$75 million, net income dropped by -48.62% YoY to -CA$62.63 million, EPS dropped by -83.78% YoY to -0.18, and gross margin dropped by -10.64% YoY to 28.8%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Alliance Global analyst Aaron Grey lowered the price target to C$1.80 from C$2.50 and maintained a Neutral rating, citing potential impacts from changes to veteran reimbursement and uncertainty around gross margins.

Wall Street analysts forecast CGC stock price to rise
4 Analyst Rating
Wall Street analysts forecast CGC stock price to rise
1 Buy
2 Hold
1 Sell
Hold
Current: 0.893
sliders
Low
1.03
Averages
2.52
High
5.9
Current: 0.893
sliders
Low
1.03
Averages
2.52
High
5.9
Canaccord
Buy
initiated
$2
AI Analysis
2026-03-27
New
Reason
Canaccord
Price Target
$2
AI Analysis
2026-03-27
New
initiated
Buy
Reason
Canaccord initiated coverage of Canopy Growth with a Buy rating and C$2 price target. Canopy is a leading cannabis company producing, distributing, and selling a "diverse range" of cannabis and cannabis-related products in key, global adult-use and medical cannabis markets, the analyst tells investors in a research note. The firm says the company's pivot from an asset-light, third-party supply model to an asset-right, in-house supply model will improve its global competitive positioning.
Alliance Global
Aaron Grey
Neutral
downgrade
2026-02-06
Reason
Alliance Global
Aaron Grey
Price Target
2026-02-06
downgrade
Neutral
Reason
Alliance Global analyst Aaron Grey lowered the firm's price target on Canopy Growth to C$1.80 from C$2.50 and keeps a Neutral rating on the shares following the fiscal Q3 report. The firm reduced the stock's multiple to reflect the potential impact from changes to veteran reimbursement and uncertainty around its gross margins.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CGC
Unlock Now

People Also Watch